07/14/2025
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2025
8:15 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2025
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K/A | |
07/08/2025
8:35 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2025
8:29 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEFA14A | |
06/26/2025
3:15 PM | Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
| Form SCHEDULE 13D/A | |
06/23/2025
3:48 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEFA14A | |
06/16/2025
9:51 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEF 14A | |
05/29/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
05/29/2025
9:14 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
3:04 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
Get the Latest News and Ratings for SLXN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/23/2025
4:00 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
8:20 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
4:01 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
05/13/2025
10:36 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025
11:12 AM | CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G/A | |
05/06/2025
7:35 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
05/01/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
04/29/2025
3:10 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form AW | |
04/29/2025
3:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/29/2025
11:10 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
04/27/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
04/23/2025
3:28 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/23/2025
8:53 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:06 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/10/2025
3:09 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/01/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
04/01/2025
3:45 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
03/28/2025
7:30 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
3:42 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
6:27 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
03/14/2025
5:59 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
7:46 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
4:31 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G | |
01/30/2025
8:26 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2025
7:56 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
11:19 AM | CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G | |
01/21/2025
4:49 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G | |
01/17/2025
5:56 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
5:44 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B4 | |
01/15/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
The Trump Dump is starting; Get out of stocks now? (Ad) The first 365 days of the Trump presidency…
Will be the best time to get rich in American history. If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a |
01/15/2025
5:02 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
4:02 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1/A | |
01/14/2025
5:19 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1/A | |
01/14/2025
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
5:00 AM | Peled Amnon (Reporting)
Silexion Therapeutics (Issuer)
Silexion Therapeutics Corp (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/17/2024
6:08 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:41 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
12/10/2024
8:42 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
12/10/2024
7:48 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:00 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:05 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/29/2024
5:06 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/27/2024
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:30 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:32 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/20/2024
5:15 AM | Guangzhou Sino-Israel Bio-Industry Investment Fund LLP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SC 13D | |
11/14/2024
8:03 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:30 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
4:24 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/22/2024
8:02 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEF 14A | |
10/16/2024
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
10/16/2024
8:32 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
10/10/2024
4:00 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form PRE 14A | |
10/09/2024
5:04 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/01/2024
5:53 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
6:10 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:06 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
09/18/2024
3:32 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
09/17/2024
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
09/09/2024
6:33 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/09/2024
7:00 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:48 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/22/2024
5:44 PM | Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
| Form SC 13D | |
08/22/2024
4:23 PM | Moringa Sponsor, LP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SC 13D | |
08/21/2024
3:45 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
6:38 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Lushi Avner (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:43 PM | Abramov Dror Yosef (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:47 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shiloah Ilan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:48 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Hadar Ilan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:48 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Horenshtein Hadar Mirit (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:49 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shirvan Mitchell (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:49 PM | Alon Ruth (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:50 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Noy Shlomo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:54 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Levin Ilan (Reporting)
Moringa Sponsor, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
7:12 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Potter Leonard (Reporting)
Wildcat Capital Management, LLC (Reporting)
Wildcat Partner Holdings, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
2:22 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form CERT | |
08/15/2024
1:45 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form 8-A12B | |
[No Brainer Gold Play]: “Show me a better investment.” (Ad) A Historic Gold Announcement Is About to Rock Wall Street?
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Click here to get Garrett’s Top Four picks now. |
07/25/2024
3:05 PM | Silexion Therapeutics (Filed by)
Biomotion Sciences (Filed by)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
| Form 425 | |
07/25/2024
3:05 PM | Silexion Therapeutics (Subject)
Biomotion Sciences (Subject)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
| Form 425 | |
07/17/2024
8:06 AM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form 424B3 | |
07/16/2024
11:15 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form EFFECT | |
